Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 11 studies | 25% ± 7% | |
intestine | 8 studies | 25% ± 11% | |
kidney | 7 studies | 20% ± 3% | |
lung | 7 studies | 31% ± 11% | |
eye | 6 studies | 24% ± 8% | |
bone marrow | 4 studies | 17% ± 1% | |
liver | 4 studies | 31% ± 20% | |
lymph node | 3 studies | 24% ± 11% | |
brain | 3 studies | 23% ± 2% | |
breast | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 10646.03 | 258 / 258 | 100% | 174.37 | 230 / 230 |
esophagus | 100% | 3723.48 | 1445 / 1445 | 100% | 95.64 | 183 / 183 |
intestine | 100% | 3596.98 | 966 / 966 | 100% | 158.06 | 527 / 527 |
liver | 100% | 4777.58 | 226 / 226 | 100% | 163.14 | 406 / 406 |
ovary | 100% | 4035.48 | 180 / 180 | 100% | 131.13 | 430 / 430 |
pancreas | 100% | 2045.31 | 328 / 328 | 100% | 127.09 | 178 / 178 |
skin | 100% | 3966.25 | 1809 / 1809 | 100% | 213.70 | 472 / 472 |
thymus | 100% | 4231.71 | 653 / 653 | 100% | 190.83 | 605 / 605 |
brain | 100% | 3719.31 | 2640 / 2642 | 100% | 242.16 | 705 / 705 |
kidney | 100% | 5002.87 | 89 / 89 | 100% | 160.14 | 900 / 901 |
prostate | 100% | 3849.31 | 245 / 245 | 100% | 197.07 | 501 / 502 |
stomach | 100% | 3691.81 | 359 / 359 | 100% | 137.16 | 285 / 286 |
bladder | 100% | 3729.90 | 21 / 21 | 100% | 169.80 | 502 / 504 |
uterus | 100% | 3268.27 | 170 / 170 | 100% | 159.93 | 457 / 459 |
lung | 100% | 2992.11 | 576 / 578 | 99% | 143.47 | 1146 / 1155 |
breast | 100% | 3678.12 | 459 / 459 | 99% | 153.72 | 1104 / 1118 |
adipose | 100% | 3553.16 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 271.71 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 260.34 | 29 / 29 |
muscle | 100% | 5197.50 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4057.34 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 147.42 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 120.05 | 1 / 1 |
blood vessel | 100% | 2798.94 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 4462.51 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 3169.94 | 906 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045454 | Biological process | cell redox homeostasis |
GO_0009749 | Biological process | response to glucose |
GO_0048678 | Biological process | response to axon injury |
GO_0014070 | Biological process | response to organic cyclic compound |
GO_0031669 | Biological process | cellular response to nutrient levels |
GO_0009725 | Biological process | response to hormone |
GO_0001666 | Biological process | response to hypoxia |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0006979 | Biological process | response to oxidative stress |
GO_0005730 | Cellular component | nucleolus |
GO_0005739 | Cellular component | mitochondrion |
GO_0043025 | Cellular component | neuronal cell body |
GO_0030425 | Cellular component | dendrite |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0008113 | Molecular function | peptide-methionine (S)-S-oxide reductase activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0015035 | Molecular function | protein-disulfide reductase activity |
GO_0033743 | Molecular function | peptide-methionine (R)-S-oxide reductase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TXN2 |
Protein name | Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Thioredoxin 2 |
Synonyms | TRX2 |
Description | FUNCTION: Important for the control of mitochondrial reactive oxygen species homeostasis, apoptosis regulation and cell viability. Possesses a dithiol-reducing activity. . |
Accessions | ENST00000411915.1 M0QXH0 Q99757 ENST00000216185.7 ENST00000416967.1 ENST00000403313.5 F8WDN2 |